Notably, analysis of TCGA colon cancer data revealed differential expression of Rap2b across CMS1 to CMS4, with Rap2b showing the highest expression in CMS1 compared to the other subtypes (Fig. S9A). This evidence concerns the gene RAP2B and colonic neoplasm.